Last reviewed · How we verify
NCT05241912
Supernormal Oxygen Delivery for Patients With Severe Burns
EARLY_PHASE1 trial testing Dobutamine in Burn Surgery in 100 participants. Status unknown.
1 June 2023
Quick facts
| Lead sponsor | Guangzhou Red Cross Hospital |
|---|---|
| Phase | EARLY_PHASE1 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | prevention |
| Enrollment | 100 |
| Start date | 28 February 2022 |
| Primary completion | 1 June 2023 |
| Estimated completion | 1 June 2023 |
| Sites | 1 location across China |
Drugs / interventions tested
- Dobutamine (DOBUTAMINE) — full drug profile →
Conditions studied
- Burn Surgery — all drugs for Burn Surgery →
- Dobutamine — all drugs for Dobutamine →
Sponsor
Guangzhou Red Cross Hospital
Who can join
Adults 18 to 60, any sex, with Burn Surgery or Dobutamine. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a randomized double-blinded study to investigate in which the groups are designated as the control group and the goal-directed fluid therapy group to further evaluate significant differences in rate of complications during burn surgery.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05241912
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Dobutamine
Trials testing the same drug.
- NCT07406477 — The PROTECT-HIE Pilot Trial · Phase 2 · not yet recruiting
- NCT06462313 — Dobutamine for Management of Surgical Patients With Septic Shock · NA · completed
- NCT05953142 — Use of Dobutamine in Patients With Sepsis and Maintained Hypoperfusion After Initial Volemic Resuscitation. · Phase 2 · unknown
- NCT05944146 — Consistency of Carotid Doppler Blood Flow and Thermodilution Technique · NA · recruiting
- NCT05196815 — Novel Echocardiographic and Invasive Haemodynamic Measurements in the Assessment of Patients Low Flow Low Gradient Aorti · NA · completed
Other Guangzhou Red Cross Hospital trials
Trials by the same sponsor.
- NCT04934761 — Study on the Effect of Capacity Shock Intervention Under Goal-directed Hemodynamic Management on P-V Loop · NA · completed
- NCT05221788 — Effect of Goal-directed Hemodynamic Therapy on Short-term Postoperative Complications in Patients With Extensive Burns · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05241912 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Guangzhou Red Cross Hospital
- Last refreshed: 16 February 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05241912.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing